摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(4,5-dihydro-4-oxo-10H-imidazo[1,2-a]indeno-[1,2-e]pyrazin-10-yl)glycolic acid | 173155-72-1

中文名称
——
中文别名
——
英文名称
(4,5-dihydro-4-oxo-10H-imidazo[1,2-a]indeno-[1,2-e]pyrazin-10-yl)glycolic acid
英文别名
10-(1-carboxy-1-hydroxymethyl)-5H,10H-imidazo[1,2-a]indeno[1,2-e]pyrazin-4-one;(4,5-dihydro-4-oxo-10H-imidazo(1,2-a]indeno[1,2-e]pyrazin-10-yl)glycolic acid;2-hydroxy-2-(7-oxo-2,5,8-triazatetracyclo[7.7.0.02,6.010,15]hexadeca-1(9),3,5,10,12,14-hexaen-16-yl)acetic acid
(4,5-dihydro-4-oxo-10H-imidazo[1,2-a]indeno-[1,2-e]pyrazin-10-yl)glycolic acid化学式
CAS
173155-72-1
化学式
C15H11N3O4
mdl
——
分子量
297.27
InChiKey
DNQQOSSJASAJQW-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    -0.1
  • 重原子数:
    22
  • 可旋转键数:
    2
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.13
  • 拓扑面积:
    104
  • 氢给体数:
    3
  • 氢受体数:
    5

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    (4,5-dihydro-4-oxo-10H-imidazo[1,2-a]indeno-[1,2-e]pyrazin-10-yl)glycolic acid盐酸硫酸乙酸酐铁粉potassium nitrate 、 zinc(II) chloride 作用下, 生成 methyl (8-amino-4,5-dihydro-4-oxo-10H-imidazo[1,2-a]indeno[1,2-e]pyrazin-10-yl)acetate
    参考文献:
    名称:
    8-Methylureido-4,5-dihydro-4-oxo-10 H -imidazo[1,2- a ]indeno-[1,2- e ]pyrazines: highly potent in vivo AMPA antagonists
    摘要:
    A novel series of readily water soluble 8-methylureido-4,5-dihydro-4-oxo-10H-imidazo[1,2-a]indeno[1,2-e]pyrazines were synthesized. The -10-yl acetic acid ((+)-3) and -10-carboxylidene (4) derivatives exhibit potent affinities (IC50 = 4 and 19 nM, respectively) and antagonist properties (IC50 = 2 and 3 nM, respectively) at the ionotropic AMPA receptor. These compounds also display anticonvulsant properties against both electrically and sound-induced convulsions in mice after ip, sc and iv administration with ED50 values between 0.9 and 11 mg/kg, thus suggesting adequate brain penetration. (C) 2000 Elsevier Science Ltd. All rights reserved.
    DOI:
    10.1016/s0960-894x(00)00054-8
  • 作为产物:
    描述:
    乙醛酸5H,10H-imidazo<1,2-a>indeno<1,2-e>pyrazin-4-one 在 sodium hydride 作用下, 以 N,N-二甲基甲酰胺 为溶剂, 以64%的产率得到(4,5-dihydro-4-oxo-10H-imidazo[1,2-a]indeno-[1,2-e]pyrazin-10-yl)glycolic acid
    参考文献:
    名称:
    8-Methylureido-4,5-dihydro-4-oxo-10 H -imidazo[1,2- a ]indeno-[1,2- e ]pyrazines: highly potent in vivo AMPA antagonists
    摘要:
    A novel series of readily water soluble 8-methylureido-4,5-dihydro-4-oxo-10H-imidazo[1,2-a]indeno[1,2-e]pyrazines were synthesized. The -10-yl acetic acid ((+)-3) and -10-carboxylidene (4) derivatives exhibit potent affinities (IC50 = 4 and 19 nM, respectively) and antagonist properties (IC50 = 2 and 3 nM, respectively) at the ionotropic AMPA receptor. These compounds also display anticonvulsant properties against both electrically and sound-induced convulsions in mice after ip, sc and iv administration with ED50 values between 0.9 and 11 mg/kg, thus suggesting adequate brain penetration. (C) 2000 Elsevier Science Ltd. All rights reserved.
    DOI:
    10.1016/s0960-894x(00)00054-8
点击查看最新优质反应信息

文献信息

  • Imidazo (1,2-A)-Indeno (1,2-E) pyrazin-4-one derivatives and
    申请人:Rhone-Poulenc Rorer S.A.
    公开号:US05807859A1
    公开(公告)日:1998-09-15
    Pharmaceutical compositions containing, as the active principle, compounds of formula (I): ##STR1## wherein R, R.sub.1 and R.sub.2 are as defined in the description, or salts thereof, the novel compounds of formula (I), and the preparation thereof. The compounds of formula (I) have valuable pharmacological properties and are alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor antagonists, this receptor also being known as the quisqualate receptor. Furthermore, the compounds of formula (I) are non-competitive N-methyl-D-aspartate (NDMA) receptor antagonists, and particularly NMDA receptor glycine modulation site ligands.
    含有作为活性原理的化合物的药物组合物,其化学式为(I):##STR1##其中R、R.sub.1和R.sub.2如描述中所定义,或其盐,化学式(I)的新化合物及其制备方法。化学式(I)的化合物具有有价值的药理特性,是α-氨基-3-羟基-5-甲基-4-异恶唑丙酸(AMPA)受体拮抗剂,该受体也被称为喹氨酸受体。此外,化学式(I)的化合物是非竞争性N-甲基-D-天冬氨酸(NDMA)受体拮抗剂,特别是NMDA受体甘氨酸调节位点配体。
  • DERIVES D'IMIDAZO[1,2-a]INDENO[1,2-e]PYRAZIN-4-ONE ET COMPOSITIONS PHARMACEUTIQUES LES CONTENANT
    申请人:Aventis Pharma S.A.
    公开号:EP0752992B1
    公开(公告)日:2001-05-30
  • US5807859A
    申请人:——
    公开号:US5807859A
    公开(公告)日:1998-09-15
  • 8-Methylureido-4,5-dihydro-4-oxo-10 H -imidazo[1,2- a ]indeno-[1,2- e ]pyrazines: highly potent in vivo AMPA antagonists
    作者:Serge Mignani、Georg Andrees Bohme、Alain Boireau、Michel Cheve、Dominique Damour、Marc-Williams Debono、Arielle Genevois-Borella、Assunta Imperato、Patrick Jimonet、Jeremy Pratt、John C.R. Randle、Yves Ribeill、Marc Vuilhorgne、Jean-Marie Stutzmann
    DOI:10.1016/s0960-894x(00)00054-8
    日期:2000.3
    A novel series of readily water soluble 8-methylureido-4,5-dihydro-4-oxo-10H-imidazo[1,2-a]indeno[1,2-e]pyrazines were synthesized. The -10-yl acetic acid ((+)-3) and -10-carboxylidene (4) derivatives exhibit potent affinities (IC50 = 4 and 19 nM, respectively) and antagonist properties (IC50 = 2 and 3 nM, respectively) at the ionotropic AMPA receptor. These compounds also display anticonvulsant properties against both electrically and sound-induced convulsions in mice after ip, sc and iv administration with ED50 values between 0.9 and 11 mg/kg, thus suggesting adequate brain penetration. (C) 2000 Elsevier Science Ltd. All rights reserved.
查看更多

同类化合物

咪唑并[1,2-a]噻吩并[3,2-E]吡嗪-5(4H)-酮 8-羟基咪唑并[1,2-a]吡嗪 5H,10H-二咪唑并[1,2-a:1,2-d]吡嗪-5,10-二酮 5H,10H-二咪唑并[1,2-a:1',5'-d]吡嗪-5,10-二酮 5,6,7,8-四氢-4H-环戊二烯并[E]咪唑并[1,2-a]吡嗪-4-酮 8-(3-benzylureido)-5H,10H-imidazo[1,2-a]indeno[1,2-e]pyrazine-4-one 8-(3-butylureido)-5H,10H-imidazo[1,2-a]indeno[1,2-e]pyrazine-4-one 8-(3-isopropylureido)-5H,10H-imidazo[1,2-a]indeno[1,2-e]pyrazine-4-one 2-nitroimidazo[1,2-a]pyrazin-8(7H)-one 8-(4-methylpentanoyl)amino-5H,10H-imidazo[1,2-a]indeno[1,2-e]pyrazine-4-one 3-(10-methyl-4,5-dihydro-4-oxo-10H-imidazo-[1,2-a]indeno[1,2-e]pyrazin-10-yl)propionitrile 10-[(1-methylimidazol-5-yl)methylene]-5H,10H-imidazo[1,2-a]indeno[1,2-e]-pyrazin-4-one hydrochloride 8-(3-tert-butylureido)-5H,10H-imidazo[1,2-a]indeno[1,2-e]pyrazine-4-one 8-(3-methylthioureido)-5H,10H-imidazo[1,2-a]indeno[1,2-e]pyrazine-4-one 10-formamido-5H,10H-imidazo[1,2-a]indeno[1,2-e]-pyrazin-4-one 10-amino-5H,10H-imidazo[1,2-a]indeno[1,2-e]-pyrazin-4-one hydrochloride 8-hydroxy-5H,10H-imidazo[1,2-a]indeno[1,2-e]pyrazine-4-one 8-Methoxy-5H,10H-imidazo[1,2-a]indeno[1,2-e]pyrazine-4-one 8-[3-morpholinoureido]-5H,10H-imidazo[1,2-a]indeno[1,2-e]-pyrazine-4-one hydrate 7-chloro-10-methylamino-5H,10H-imidazo-[1,2-a]indeno[1,2-e]pyrazin-4-one hydrochloride 7-chloro-10-formamido-5H,10H-imidazo[1,2-a]indeno[1,2-e]pyrazin-4-one 10-acetamido-7-chloro-5H,10H-imidazo[1,2-a]indeno[1,2-e]pyrazin-4-one 10-(2-pyridylmethyl)-5H,10H-imidazo[1,2-a]indeno-[1,2-e]pyrazin-4-one 10-(4-imidazolylmethyl)-5H,10H-imidazo[1,2-a]-indeno[1,2-e]pyrazin-4-one 10-(pyridin-2-ylmethylene)-5H,10H-imidazo[1,2-a]indeno[1,2-e]pyrazin-4-one 10-(4-imidazolylmethylene)-5H,10H-imidazo[1,2-a]indeno[1,2-e]pyrazin-4-one 5H,10H-8-aminoimidazo[1,2-a]indeno[1,2-e]pyrazine-4-one monohydrochloride 10-(carboxymethylene)-8-(3-methylureido)-5H,10H-imidazo[1,2-a]indeno[1,2-e]pyrazin-4-one 8-amino-10-(carboxymethylene)-5H,10H-imidazo[1,2-a]indeno[1,2-e]pyrazin-4-one dihydrochloride 8-ureido-5H,10H-imidazo[1,2-a]indeno[1,2-e]pyrazine-4-one [4,5-dihydro-4-oxo-10H-imidazo[1,2-a]indeno[1,2-e]pyrazin-8-yl]acetic acid 10-(2-methyl-1-propenyl)-5H,10H-imidazo[1,2-a]indeno[1,2-e]pyrazin-4-one RPR 119990 3-(9-carboxymethyl-4-oxo-5,10-dihydroimidazo[1,2-a]indeno[1,2-e]pyrazin-2-yl]propionic acid 10-[4-(imidazol-1-yl)butyl]-10-methyl-5H,10H-imidazo[1,2-a]indeno[1,2-e]pyrazin-4-one 12-Methyl-3-thia-1,7,10-triazatricyclo[7.3.0.02,6]dodeca-2(6),4,9,11-tetraen-8-one 3-bromo-7-methyl-imidazo[1,2-a]pyrazin-8-one 5-chloro-7-methyl-8-oxo-6-phenyl-7,8-dihydroimidazo[1,2-a]-pyrazine-3-carbaldehyde ethyl 9-(diethoxyphosphorylmethyl)-4-oxo-5,10-dihydroimidazo[1,2-a]indeno[1,2-e]pyrazine-2-carboxylate ethyl 8-fluoro-4-oxo-4,5-dihydro-10H-imidazo[1,2-a]indeno[1,2-e]pyrazine-2-carboxylate 2-methyl-7H-imidazo[1,2-a]pyrazin-8-one 2-Methyl-7-[(1-phenylcyclopropyl)methyl]imidazo[1,2-a]pyrazin-8-one 3-bromo-2-methyl-7-(1-phenyl-cyclopropylmethyl)-7H-imidazo[1,2-a]pyrazin-8-one 5-chloro-7-(4-methoxybenzyl)-8-oxo-7,8-dihydroimidazo[1,2-a]-pyrazine-3-carbaldehyde 10-hydroxymethylene-5H,10H-imidazo[1,2-a]indeno[1,2-e]pyrazin-4-one 10-(carboxymethylene)-5H,10H-imidazo[1,2-a]indeno-[1,2-e]pyrazin-4-one 10-(carboxymethyl)-5H,10H-imidazo[1,2-a]indeno[1,2-e]-pyrazin-4-one 8-oxo-7,8-dihydroimidazo[1,2-a]pyrazine hydrochloride 10-amino-5H,10H-imidazo[1,2-a]indeno[1,2-e]-pyrazin-4-one 10-(4-phenylbutyramido)-5H,10H-imidazo[1,2-a]-indeno[1,2-e]pyrazin-4-one